Regulations.gov document
Patent Extension Application from Myovant Sciences GmbH on behalf of Takeda Pharmaceutical…
Other · FDA-2022-E-0937 · posted May 27, 2022
Key facts
| Document ID | FDA-2022-E-0937-0001 |
|---|---|
| Title | Patent Extension Application from Myovant Sciences GmbH on behalf of Takeda Pharmaceutical Company Limited |
| Document type | Other |
| Subtype | Application |
| Agency | FDA |
| Docket | FDA-2022-E-0937 |
| Posted | May 27, 2022 |
| Comment period opens | May 27, 2022 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: